Medical and Pediatric Oncology · 1979 · 20 citations · 8 references
MedicinePharmacologyPharmacotherapyCancer PharmacologyChemotherapyOncology PharmacotherapyChemotherapy In Hematologic MalignanciesHematologic Malignancy PharmacotherapyHematologic Malignancy TherapyPediatric ChemotherapyPediatric Hematologic Malignancy Chemotherapy
A prospective study for histiocytosis X was designed to determine whether "good risk" patients, ie, those without evidence of dysfunction of liver, lung, or hemopoietic system, would respond to single agent therapy; in this case chlorambucil (CMB) used in a dose of 5 mgm/m2/day. If there was no response after an adequate trial period, treatment was initiated with four drugs using a combination of prednisone, vinblastine, cyclophosphamide and methotrexate. There were 26 evaluable patients, 57% of whom were less than two years of age at onset of therapy. There were three complete and four partial responses to CMB for a response rate of 26.9%. Sixteen patients received an adequate trial of four-drug therapy with three complete and two partial responses for a response rate of 33%. These responses were inferior to those previously reported for either single agents or combined therapy in histiocytosis X.
8
Histiocytosis X—an analysis of prognostic factors
M. Eugene Lahey · The Journal of Pediatrics · 1975 · 287 citations
Medicine, Hematology, Pathology +12
Archives of Disease in Childhood · 1974 · 221 citations
Medicine, Pediatrics, Radiology +8
Histiocytosis X—comparison of three treatment regimens
M. Eugene Lahey · The Journal of Pediatrics · 1975 · 138 citations
Medicine, Hematology, Pathology +7
Prognosis in reticuloendotheliosis in children
M. Eugene Lahey · The Journal of Pediatrics · 1962 · 126 citations
Medicine, Pathology, Pediatrics +5